Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 3/20 | 0.63 |
| ▸ | NOS2 | P35228 | 1/20 | 0.44 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 4/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | RGS12 | O14924 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL211770 | 1.00 | MIF (0.63) | MIFNOS2ADRA2CKDM4ELMNA | |
| SCHEMBL7980 | 1.00 | MIF (0.63) | MIFNOS2ADRA2CKDM4ELMNA | |
| SCHEMBL27902285 | 0.94 | MIF (0.57) | MIFNOS2ADRA2CKDM4ELMNA | |
| SCHEMBL23070416 | 0.94 | MIF (0.57) | MIFNOS2ADRA2CKDM4ELMNA | |
| SCHEMBL443529 | 0.88 | MIF (0.46) | MIFNOS2CYP3A4 | |
| SCHEMBL28671467 | 0.88 | MIF (0.50) | MIFCYP2C9PKMCYP2C19 | |
| SCHEMBL22279429 | 0.88 | MIF (0.50) | MIFCYP2C9PKMCYP2C19 | |
| SCHEMBL7192060 | 0.84 | MIF (0.45) | MIFNOS2KDM4ELMNAHIF1A | |
| SCHEMBL22265179 | 0.83 | MIF (0.46) | MIFADRA2CLMNAADRA2AALDH1A1 | |
| SCHEMBL22265178 | 0.83 | MIF (0.46) | MIFADRA2CLMNAADRA2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1740 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119306632-A | Process for the preparation of isocyanate compounds comprising non-chlorinated derivatives and compositions thereof | KS试验研究株式会社 | 2025-01-14 | — | — | CN | claimed |
| CN-119306631-A | Process for the preparation of isocyanate compounds comprising non-chlorinated derivatives and compositions thereof | KS试验研究株式会社 | 2025-01-14 | — | — | CN | claimed |
| CN-119161580-A | Amide group-containing polydisulfide degradable high polymer material and preparation method thereof | 衢州化工新材料创新研究院 | 2024-12-20 | — | — | CN | claimed |
| CN-114790163-B | Glimepiride Process for the preparation of intermediates | 江苏星诺医药科技有限公司 | 2024-08-27 | — | — | CN | claimed |
| US-20240154124-A1 | NEGATIVE ELECTRODE PLATE AND LITHIUM-ION BATTERY COMPRISING SAME | ZHUHAI COSMX BATTERY CO., LTD. (CN) | 2024-05-09 | — | — | US | claimed |
| US-11760750-B1 | Process for preparing levoketoconazole | NURAY CHEMICALS PRIVATE LIMITED (IN) | 2023-09-19 | — | — | US | claimed |
| CN-115011053-B | High-reflection fractal structure hydrogel, and preparation method and application thereof | 中国科学院苏州纳米技术与纳米仿生研究所 | 2023-08-01 | — | — | CN | claimed |
| CN-116217444-A | Photo-generated chiral radical molecule with circularly polarized luminescence property based on triarylamine derivative | 中国科学院化学研究所 | 2023-06-06 | — | — | CN | claimed |
| US-20230151136-A1 | CATALYST COMPOSITION FOR POLYURETHANES | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-05-18 | — | — | US | claimed |
| US-20230134280-A1 | CATALYSTS FOR THE FORMATION OF POLYURETHANES | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-05-04 | — | — | US | claimed |
| EP-0566567-B1 | ANTIHYPERTENSIVE BENZOPYRAN DERIVATIVES | AMERICAN HOME PROD (US) | 1997-11-19 | — | — | EP | claimed |
| US-5457212-A | Process for the preparation of enantiomerically pure thienopyran derivatives | ORTHO PHARMACEUTICAL CORPORATION (US) | 1995-10-10 | — | — | US | claimed |
| EP-0566567-A1 | ANTIHYPERTENSIVE BENZOPYRAN DERIVATIVES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1993-10-27 | — | — | EP | claimed |
| EP-0314446-B1 | NOVEL ANTIHYPERTENSIVE BENZOPYRAN DERIVATIVES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1993-09-15 | — | — | EP | claimed |
| WO-1992012153-A1 | NOVEL ANTIHYPERTENSIVE BENZOPYRAN DERIVATIVES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1992-07-23 | — | — | WO | claimed |
| EP-0493048-A1 | The process for the preparation of enantiomerically pure thienopyran derivative | ORTHO PHARMACEUTICAL CORPORATION (US) | 1992-07-01 | — | — | EP | claimed |
| EP-0120428-B1 | BENZOPYRAN ISOMERS | BEECHAM GROUP PLC (GB) | 1990-05-23 | — | — | EP | claimed |
| EP-0317085-A2 | Processed red blood cells and process for producing the same | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 1989-05-24 | — | — | EP | claimed |
| EP-0314446-A2 | Novel antihypertensive benzopyran derivatives | AMERICAN HOME PRODUCTS CORPORATION (US) | 1989-05-03 | — | — | EP | claimed |
| EP-0234353-A1 | Process for the production of tetramethyl xylylene diisocyanates | AMERICAN CYANAMID COMPANY (US) | 1987-09-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11760750-B1 | Process for preparing levoketoconazole | KHK, KYAT3, PLK3 | MIF 2851/4885NOS2 3874/4885ADRA2C 1571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.